Nantes University Hospital

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Established: 1503-01-01

Employees: 10K

Market Cap: -

Website: https://www.chu-nantes.fr

Clinical Trials

Clinical Evaluation of Integrative Practices Units Infant and Child Care for Unit Children With Typical or Atypical Autism (AUTISM)

Completed

Conditions: Autism

Interventions: Behavioral: Integrative practices

First Posted Date: 2014-06-03

Last Posted Date: 2018-12-12

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 103

Registration Number: NCT02154828

Locations: 🇫🇷
Daumezon hospital, Bouguenais, France
🇫🇷
Brive Hospital, Brive, France
🇫🇷
Inercomunal Center, Créteil, France

and more 18 locations

Pre-emptive Kidney Transplantation Quality of Life

Completed

Conditions: Kidney Transplantation
Renal Insuffiency

First Posted Date: 2014-06-03

Last Posted Date: 2024-08-27

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 390

Registration Number: NCT02154815

Locations: 🇫🇷
CHU NANTES - Hôtel Dieu-Jean Monnet - ITUN, Nantes, France
🇫🇷
CHU LYON - Hôpitla E. Herriot - Médecine de transplantation et immunoclinique, Lyon, France
🇫🇷
CHU TOULOUSE - Hôpitalt Rangueil - Service de Néphrologie, Toulouse, France

and more 2 locations

Prospective, Single-blind Study Assessing the Benefit/Risk Ratio of Internal Limiting Membrane (ILM) Peeling During Epimacular Membrane (EMM) Surgery (Peeling)

Not Applicable

Completed

Conditions: Idiopathic Epimacular Membrane

Interventions: Procedure: ILM Peeling

First Posted Date: 2014-05-23

Last Posted Date: 2023-02-10

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 213

Registration Number: NCT02146144

Locations: 🇫🇷
Clinique Sourdille, Nantes, France
🇫🇷
CHU de Dijon, Dijon, France
🇫🇷
CHU de Nantes, Nantes, France

and more 3 locations

Inter-regional Project of the Great Western Exploration Approach for Exome Molecular Causes Severe Intellectual Disability Isolated or Syndromic

Completed

Conditions: Severe Intellectual Disability

First Posted Date: 2014-05-13

Last Posted Date: 2018-12-12

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 228

Registration Number: NCT02136849

Locations: 🇫🇷
Angers University Hospital, Angers, France
🇫🇷
Brest University Hospital, Brest, France
🇫🇷
Rennes University Hospital, Rennes, France

and more 2 locations

Safety and Efficacity of Corneal Collagen Crosslinking in Infectious Keratitis (Bacterial and Fungal ): Randomized,Controlled, Prospective Study. (CXL)

Not Applicable

Terminated

Conditions: Bacterial Keratitis
Fungal Keratitis

Interventions: Drug: antibiotic treatment
Device: Crosslinking

First Posted Date: 2014-03-17

Last Posted Date: 2017-06-01

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 21

Registration Number: NCT02088970

Locations: 🇫🇷
Orignac, Nantes, France

18F-deoxyglucose (FDG) PET-CMD

Not Applicable

Completed

Conditions: Patients With Idiopathic Dilated Cardiomyopathy

Interventions: Drug: 18F-deoxyglucose (FDG)

First Posted Date: 2014-03-05

Last Posted Date: 2022-07-26

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 30

Registration Number: NCT02078141

Locations: 🇫🇷
Nantes UH, Nantes, France
🇫🇷
West Cancerology Institute/Nantes UH : PET plateform, Saint Herblain, France

Dolutegravir + Rilpivirine Switch Study (DORISS)

Phase 2

Withdrawn

Conditions: HIV Infection
HAART-treated
Virologically Controlled

Interventions: Drug: Arm 1 (intervention)
Drug: Arm 2 (control)

First Posted Date: 2014-02-24

Last Posted Date: 2015-08-28

Lead Sponsor: Nantes University Hospital

Registration Number: NCT02069834

Locations: 🇫🇷
CHU Guadeloupe, Point-a-pitre, Guadeloupe, France
🇫🇷
Chu Jean Minjoz, Besançon, France
🇫🇷
Hôpital Avicenne, Bobigny, France

and more 22 locations

Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults (SWAD)

Phase 2

Completed

Conditions: HIV-1 Infection

Interventions: Drug: Abacavir/Lamivudine/Dolutegravir

First Posted Date: 2014-02-20

Last Posted Date: 2016-02-22

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 53

Registration Number: NCT02067767

Locations: 🇫🇷
La Roche-sur-Yon Hospital, La Roche-sur-Yon, France
🇫🇷
Nantes University Hospital, Nantes, France

Vulnerability and Therapeutic Changes in Older Patients With Multiple Myeloma.

Not Applicable

Terminated

Conditions: Multiple Myeloma in Older Patients

Interventions: Other: Vulnerability and therapeutic changes in older patients with multiple myeloma.

First Posted Date: 2014-02-14

Last Posted Date: 2023-05-23

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 48

Registration Number: NCT02063113

Locations: 🇫🇷
CHD Vendée La Roche sur Yon, La Roche-sur-Yon, France
🇫🇷
CHU de Nantes, Nantes, France

ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF

Phase 4

Terminated

Conditions: Kidney Transplantation

Interventions: Drug: Anti-Thymocyte Globulins treatment
Drug: Basiliximab treatment

First Posted Date: 2014-02-06

Last Posted Date: 2017-11-21

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 19

Registration Number: NCT02056938

Locations: 🇫🇷
Nantes Universitary hospital, Nantes, France
🇫🇷
Universitary hospital of Lyon, Lyon, France
🇫🇷
Necker Hospital, Paris, France

and more 1 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy